Task
User Journey through Astek Diagnostics Website
As a healthcare professional, I understand how Astek Diagnostics tackles the challenges of UTI diagnostics and antimicrobial resistance, so that I can provide better-informed decisions about treatment options for my patients.
Success definition: Given I am on the Astek Diagnostics homepage When I click on the 'Problem' link and explore the issues it addresses, click on the 'Solution' link to learn about their approach to AMR, and finally click on the 'Grand vision' link to understand their long-term goals Then I should see detailed information on the challenges Astek Diagnostics aims to solve, the JIDDU platform's effectiveness, and the company's vision for future advancements in diagnostic technology.
Trajectory
Step 1:
Url (before/after):
https://astekdx.com/
https://astekdx.com/problem
Content (before/after):
RootWebArea Home - Astek Diagnostics, focused, url='https://astekdx.com/'
main
navigation
link Home, url='https://astekdx.com/'
link Problem, url='https://astekdx.com/problem'
Show more
link Solution, url='https://astekdx.com/solution'
link Grand vision, url='https://astekdx.com/grand-vision'
link About us, url='https://astekdx.com/about-us'
link In the news, url='https://astekdx.com/in-the-news'
link Careers, url='https://astekdx.com/careers'
link Get in touch, url='https://astekdx.com/get-in-touch'
link Linkedin, url='https://www.linkedin.com/company/astek-diagnostics/'
StaticText HEADQUARTERS
StaticText 1450 S Rolling Road,
StaticText Halethorpe,
StaticText MD 21227
progressbar value='0'
[124] link, center=(151,49), url='https://astekdx.com/'
[128] link Home, center=(978,49), url='https://astekdx.com/'
[130] link Problem, center=(1074,49), url='https://astekdx.com/problem'
[132] link Solution, center=(1182,49), url='https://astekdx.com/solution'
[134] link Grand vision, center=(1306,49), url='https://astekdx.com/grand-vision'
[136] link About us, center=(1434,49), url='https://astekdx.com/about-us'
[138] link In the news, center=(1556,49), url='https://astekdx.com/in-the-news'
[140] link Careers, center=(1672,49), url='https://astekdx.com/careers'
[142] link Get in touch, center=(1792,49), url='https://astekdx.com/get-in-touch'
main
heading 1-hour UTI detection & antibiotic sensitivity indication
image, url='https://astekdx.com/images/banner-jiddu.webp'
image
heading Better diagnostics, better treatment
heading Saving lives through antibiotic sensitivity precision diagnostics
link Solution, url='https://astekdx.com/solution'
paragraph
StaticText At Astek Diagnostics, we are creating the JIDDU system, an innovative clinical diagnostics platform that offers infection confirmation for urinary tract infections (UTIs) and antibiotic sensitivity indication within 1 hour.
StaticText The JIDDU system greatly improves diagnostic speed and accuracy, thereby reducing patient complications and pain, as well as lowering healthcare costs. It represents a significant leap forward in patient care that allows for much more timely and accurate treatment than the current standard of care. This ultimately leads to saving lives, given that 25% of sepsis cases are caused by UTIs.
StaticText Given that women get UTIs up to 30 times more often than men, the development and deployment of the JIDDU system would have major implications on FemHealth.
image, url='https://astekdx.com/images/grid/11.webp'
image, url='https://astekdx.com/images/grid/9.webp'
image, url='https://astekdx.com/images/grid/1.webp'
image, url='https://astekdx.com/images/grid/4.webp'
image, url='https://astekdx.com/images/grid/3.webp'
image, url='https://astekdx.com/images/grid/2.webp'
image, url='https://astekdx.com/images/grid/5.webp'
image, url='https://astekdx.com/images/grid/6.webp'
image, url='https://astekdx.com/images/grid/7.webp'
image, url='https://astekdx.com/images/grid/8.webp'
image, url='https://astekdx.com/images/grid/9.webp'
image, url='https://astekdx.com/images/grid/15.webp'
image, url='https://astekdx.com/images/grid/10.webp'
image, url='https://astekdx.com/images/grid/11.webp'
image, url='https://astekdx.com/images/grid/12.webp'
image, url='https://astekdx.com/images/grid/13.webp'
image, url='https://astekdx.com/images/grid/14.webp'
image, url='https://astekdx.com/images/grid/15.webp'
image, url='https://astekdx.com/images/grid/16.webp'
image, url='https://astekdx.com/images/grid/17.webp'
image, url='https://astekdx.com/images/grid/18.webp'
image, url='https://astekdx.com/images/grid/14.webp'
image, url='https://astekdx.com/images/grid/13.webp'
image, url='https://astekdx.com/images/aaron.jpg'
paragraph
StaticText "The Jiddu Platform by Astek Diagnostics is a groundbreaking advancement in point-of-care testing for UTIs. In just about an hour, it enables doctors to make real-time treatment decisions by identifying active infections and determining which antibiotics are likely to work. This is a true game changer. I’m excited to use this technology to deliver faster, more precise care for my patients, without having to depend on dipstick tests or traditional cultures that take days. It even outpaces the speed of expensive urine PCR tests currently being used."
heading Aaron Grotas, MD
link PRINE Health, url='https://prinehealth-old.projectwebtec4.com/'
paragraph
link, url='https://prinehealth-old.projectwebtec4.com/'
image, url='https://astekdx.com/images/prine.jpg'
heading UTIs are among the leading precursors of antimicrobial resistance (AMR)
heading AMR is among the biggest global health threats
link Problem, url='https://astekdx.com/problem'
image, url='https://astekdx.com/images/home-problem-section-women.webp'
image, url='https://astekdx.com/images/women-foreground.svg'
heading A leap forward from the current “gold standard” of UTI diagnostics and treatment
heading Rapid and actionable results within 1 hour
link Solution, url='https://astekdx.com/solution'
image, url='https://astekdx.com/images/home-solution-image.webp'
image
heading Going beyond UTI diagnostics and treatment
heading Developing a universal diagnostic system which tests 4 sample types
link Grand vision, url='https://astekdx.com/grand-vision'
heading Current focus
image, url='https://astekdx.com/images/urine.webp'
heading Urine
heading In development
image, url='https://astekdx.com/images/csf.webp'
heading CSF
image, url='https://astekdx.com/images/effluent.webp'
heading Effluent
image, url='https://astekdx.com/images/blood.webp'
heading Blood
heading How it started
heading Mustafa Al Adhami, PhD
heading CEO at Astek Diagnostics
paragraph
StaticText In 2021, the growing issue of antibiotic resistant UTIs became personal for Mustafa. His grandfather was suffered from agonizing pain for days before being diagnosed with a UTI and being treated with the right antibiotic. Mustafa’s family felt entirely helpless during this experience.
StaticText Recognizing the need for a solution, Mustafa founded Astek Diagnostics. Ever since, he has been dedicated to revolutionizing the way antibiotics are prescribed to patients.
StaticText Today, in partnership with key healthcare institutions such, including The University of Maryland Medical Center and MedStar Health, Astek Diagnostics has achieved exceptional initial results and is well on its way to a market entry in 2025.
link About Astek, url='https://astekdx.com/about-us'
image, url='https://astekdx.com/images/home-about-us.webp'
tablist, orientation='horizontal'
tab Current Pilots, selected=True
heading Current Pilots
tab Industry Recognition, selected=False
heading Industry Recognition
tab Scientific Grants, selected=False
heading Scientific Grants
tab Investors, selected=False
heading Investors
link, url='https://www.umms.org/ummc'
image, url='https://astekdx.com/images/tabs/current-pilots/1.webp'
link, url='https://www.medstarhealth.org/'
image, url='https://astekdx.com/images/tabs/current-pilots/2.webp'
link, url='https://www.mrrch.com/'
image, url='https://astekdx.com/images/tabs/current-pilots/3.webp'
heading In the news
link ASTEK DIAGNOSTICS DEC 19, 2024 Astek Diagnostics Achieves Key Milestone with Successful Completion of Q4-50 Alpha Feasibility Study, url='https://astekdx.com/press-release-12-19-24'
StaticText ASTEK DIAGNOSTICS
StaticText DEC 19, 2024
heading Astek Diagnostics Achieves Key Milestone with Successful Completion of Q4-50 Alpha Feasibility Study
link ASTEK DIAGNOSTICS NOV 21, 2024 Astek Diagnostics Welcomes Suzanne Lynn Groah, MD, MSPH as Chief Medical Officer to Lead Clinical Strategy and Drive Innovation, url='https://astekdx.com/press-release-11-21-24'
StaticText ASTEK DIAGNOSTICS
StaticText NOV 21, 2024
heading Astek Diagnostics Welcomes Suzanne Lynn Groah, MD, MSPH as Chief Medical Officer to Lead Clinical Strategy and Drive Innovation
link ASTEK DIAGNOSTICS OCT 29, 2024 Astek Diagnostics Completes Successful Pre-Submission Meeting with FDA for Jiddu™ Platform, url='https://astekdx.com/press-release-10-29-24'
StaticText ASTEK DIAGNOSTICS
StaticText OCT 29, 2024
heading Astek Diagnostics Completes Successful Pre-Submission Meeting with FDA for Jiddu™ Platform
link 360DX SEP 27, 2024 Startup Astek Dx Aims to Deliver One-Hour UTI Testing With Optical Test System, url='https://astekdx.com/press-release-09-27-24'
StaticText 360DX
StaticText SEP 27, 2024
heading Startup Astek Dx Aims to Deliver One-Hour UTI Testing With Optical Test System
link View more in news, url='https://astekdx.com/in-the-news'
image, url='https://astekdx.com/images/jiddu-footer.webp'
heading Be among the first to experience our technology
link Get in touch, url='https://astekdx.com/get-in-touch'
separator, orientation='horizontal'
link, url='https://astekdx.com/'
image, url='https://astekdx.com/images/tile-inverted.svg'
StaticText WHAT WE DO
link Home, url='https://astekdx.com/'
link Problem, url='https://astekdx.com/problem'
link Solution, url='https://astekdx.com/solution'
link Grand vision, url='https://astekdx.com/grand-vision'
StaticText NEWS
link In the news, url='https://astekdx.com/in-the-news'
StaticText COMPANY
link Careers, url='https://astekdx.com/careers'
link Get in touch, url='https://astekdx.com/get-in-touch'
separator, orientation='horizontal'
StaticText CONTACT
link info@astekdx.com, url='https://astekdx.com/get-in-touch'
StaticText HEADQUARTERS
StaticText 1450 S Rolling Road,
StaticText Halethorpe, Baltimore,
StaticText MD 21227
separator, orientation='horizontal'
link Linkedin, url='https://www.linkedin.com/company/astek-diagnostics/'
StaticText © 2023 Astek Diagnostics
RootWebArea Problem - Astek Diagnostics, focused, url='https://astekdx.com/problem'
main
navigation
link Home, url='https://astekdx.com/'
link Problem, url='https://astekdx.com/problem'
Show more
link Solution, url='https://astekdx.com/solution'
link Grand vision, url='https://astekdx.com/grand-vision'
link About us, url='https://astekdx.com/about-us'
link In the news, url='https://astekdx.com/in-the-news'
link Careers, url='https://astekdx.com/careers'
link Get in touch, url='https://astekdx.com/get-in-touch'
link Linkedin, url='https://www.linkedin.com/company/astek-diagnostics/'
StaticText HEADQUARTERS
StaticText 1450 S Rolling Road,
StaticText Halethorpe,
StaticText MD 21227
progressbar value='0'
[124] link, center=(151,49), url='https://astekdx.com/'
[128] link Home, center=(978,49), url='https://astekdx.com/'
[130] link Problem, center=(1074,49), focused, url='https://astekdx.com/problem'
[132] link Solution, center=(1182,49), url='https://astekdx.com/solution'
[134] link Grand vision, center=(1306,49), url='https://astekdx.com/grand-vision'
[136] link About us, center=(1434,49), url='https://astekdx.com/about-us'
[138] link In the news, center=(1556,49), url='https://astekdx.com/in-the-news'
[140] link Careers, center=(1672,49), url='https://astekdx.com/careers'
[142] link Get in touch, center=(1792,49), url='https://astekdx.com/get-in-touch'
main
image, url='https://astekdx.com/images/problem-cover.webp'
heading The problem
heading Antimicrobial Resistance (AMR) is one of the top 10 global health threats facing humanity
heading AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines, thus making infections much harder to treat and increasing the risk of disease spread, severe illness and death.
heading AMR overview
heading Mainly caused by overuse and misuse of antimicrobials
heading Leads to the emergence of new and more resistant strains of bacteria
heading The economic cost of AMR in the US alone is estimated at c.$55 billion per year
heading Inadequate diagnostics
heading Improper antibiotic prescription
heading Development of resistant strains & serious complications like sepsis
heading Even harder infections
heading Inadequate diagnostics
heading Super bug
image, url='https://astekdx.com/images/super-bug.webp'
image, url='https://astekdx.com/images/amr-cover.webp'
heading AMR related to UTIs
heading High rates of resistance to antibiotics used in UTI treatment has been observed globally.
heading UTIs are among the most common bacterial infections leading to clinic visits and can cause serious sequelae, such as renal damage and urosepsis.
paragraph
StaticText In 2019, the global incident cases of UTI were 0.4 billion, an increase of 60.40% from 1990. Consistent with the rapid increase in the UTI cases, bacterial AMR in UTIs has also rapidly increased.
StaticText 8.1m
heading UTI-caused hospital visits per year in the US
paragraph
StaticText $1.6B of annual cost from mistreated UTIs that require hospitalization
StaticText 47%
heading treated with inappropriate antibiotics
paragraph
StaticText Empiric therapy causes antibiotic resistant bacteria to increase by 300% per annum
StaticText 25%
heading of sepsis cases are caused by UTIs
paragraph
StaticText 68,000 lives lost per annum in the US alone as a result of UTI-related sepsis cases
StaticText 72h
heading test processing for urine cultures takes 24-72 hrs
paragraph
StaticText Current testing is slow
StaticText 50%
heading accuracy of dipstick urinalysis
paragraph
StaticText Current testing is inaccurate
image, url='https://astekdx.com/images/jiddu-footer.webp'
heading Be among the first to experience our technology
link Get in touch, url='https://astekdx.com/get-in-touch'
separator, orientation='horizontal'
link, url='https://astekdx.com/'
image, url='https://astekdx.com/images/tile-inverted.svg'
StaticText WHAT WE DO
link Home, url='https://astekdx.com/'
link Problem, url='https://astekdx.com/problem'
link Solution, url='https://astekdx.com/solution'
link Grand vision, url='https://astekdx.com/grand-vision'
StaticText NEWS
link In the news, url='https://astekdx.com/in-the-news'
StaticText COMPANY
link Careers, url='https://astekdx.com/careers'
link Get in touch, url='https://astekdx.com/get-in-touch'
separator, orientation='horizontal'
StaticText CONTACT
link info@astekdx.com, url='https://astekdx.com/get-in-touch'
StaticText HEADQUARTERS
StaticText 1450 S Rolling Road,
StaticText Halethorpe, Baltimore,
StaticText MD 21227
separator, orientation='horizontal'
link Linkedin, url='https://www.linkedin.com/company/astek-diagnostics/'
StaticText © 2023 Astek Diagnostics
Reasoning for action: By clicking the 'Problem' link, I am accessing the section of the Astek Diagnostics website that details the specific challenges related to urinary tract infections (UTIs) and antimicrobial resistance (AMR). Understanding these challenges will provide me with the foundational knowledge necessary to appreciate the context in which Astek Diagnostics operates, paving the way for my future steps to learn about their solutions and vision.
Action: click(130) # Click on the 'Problem' link to explore the issues Astek Diagnostics addresses.
Change Description: After clicking the 'Problem' link, the browser navigated to the 'Problem' page of Astek Diagnostics, revealing a new set of headings and paragraphs that detail the issue of Antimicrobial Resistance (AMR) and its implications for urinary tract infections (UTIs), along with new images highlighting these challenges and the economic impact of AMR.
Screenshot before:Screenshot after:---
Step 2:
Url (before/after):
https://astekdx.com/problem
https://astekdx.com/solution
Content (before/after):
RootWebArea Problem - Astek Diagnostics, focused, url='https://astekdx.com/problem'
main
navigation
link Home, url='https://astekdx.com/'
link Problem, url='https://astekdx.com/problem'
Show more
link Solution, url='https://astekdx.com/solution'
link Grand vision, url='https://astekdx.com/grand-vision'
link About us, url='https://astekdx.com/about-us'
link In the news, url='https://astekdx.com/in-the-news'
link Careers, url='https://astekdx.com/careers'
link Get in touch, url='https://astekdx.com/get-in-touch'
link Linkedin, url='https://www.linkedin.com/company/astek-diagnostics/'
StaticText HEADQUARTERS
StaticText 1450 S Rolling Road,
StaticText Halethorpe,
StaticText MD 21227
progressbar value='0'
[124] link, center=(151,49), url='https://astekdx.com/'
[128] link Home, center=(978,49), url='https://astekdx.com/'
[130] link Problem, center=(1074,49), focused, url='https://astekdx.com/problem'
[132] link Solution, center=(1182,49), url='https://astekdx.com/solution'
[134] link Grand vision, center=(1306,49), url='https://astekdx.com/grand-vision'
[136] link About us, center=(1434,49), url='https://astekdx.com/about-us'
[138] link In the news, center=(1556,49), url='https://astekdx.com/in-the-news'
[140] link Careers, center=(1672,49), url='https://astekdx.com/careers'
[142] link Get in touch, center=(1792,49), url='https://astekdx.com/get-in-touch'
main
image, url='https://astekdx.com/images/problem-cover.webp'
heading The problem
heading Antimicrobial Resistance (AMR) is one of the top 10 global health threats facing humanity
heading AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines, thus making infections much harder to treat and increasing the risk of disease spread, severe illness and death.
heading AMR overview
heading Mainly caused by overuse and misuse of antimicrobials
heading Leads to the emergence of new and more resistant strains of bacteria
heading The economic cost of AMR in the US alone is estimated at c.$55 billion per year
heading Inadequate diagnostics
heading Improper antibiotic prescription
heading Development of resistant strains & serious complications like sepsis
heading Even harder infections
heading Inadequate diagnostics
heading Super bug
image, url='https://astekdx.com/images/super-bug.webp'
image, url='https://astekdx.com/images/amr-cover.webp'
heading AMR related to UTIs
heading High rates of resistance to antibiotics used in UTI treatment has been observed globally.
heading UTIs are among the most common bacterial infections leading to clinic visits and can cause serious sequelae, such as renal damage and urosepsis.
paragraph
StaticText In 2019, the global incident cases of UTI were 0.4 billion, an increase of 60.40% from 1990. Consistent with the rapid increase in the UTI cases, bacterial AMR in UTIs has also rapidly increased.
StaticText 8.1m
heading UTI-caused hospital visits per year in the US
paragraph
StaticText $1.6B of annual cost from mistreated UTIs that require hospitalization
StaticText 47%
heading treated with inappropriate antibiotics
paragraph
StaticText Empiric therapy causes antibiotic resistant bacteria to increase by 300% per annum
StaticText 25%
heading of sepsis cases are caused by UTIs
paragraph
StaticText 68,000 lives lost per annum in the US alone as a result of UTI-related sepsis cases
StaticText 72h
heading test processing for urine cultures takes 24-72 hrs
paragraph
StaticText Current testing is slow
StaticText 50%
heading accuracy of dipstick urinalysis
paragraph
StaticText Current testing is inaccurate
image, url='https://astekdx.com/images/jiddu-footer.webp'
heading Be among the first to experience our technology
link Get in touch, url='https://astekdx.com/get-in-touch'
separator, orientation='horizontal'
link, url='https://astekdx.com/'
image, url='https://astekdx.com/images/tile-inverted.svg'
StaticText WHAT WE DO
link Home, url='https://astekdx.com/'
link Problem, url='https://astekdx.com/problem'
link Solution, url='https://astekdx.com/solution'
link Grand vision, url='https://astekdx.com/grand-vision'
StaticText NEWS
link In the news, url='https://astekdx.com/in-the-news'
StaticText COMPANY
link Careers, url='https://astekdx.com/careers'
link Get in touch, url='https://astekdx.com/get-in-touch'
separator, orientation='horizontal'
StaticText CONTACT
link info@astekdx.com, url='https://astekdx.com/get-in-touch'
StaticText HEADQUARTERS
StaticText 1450 S Rolling Road,
StaticText Halethorpe, Baltimore,
StaticText MD 21227
separator, orientation='horizontal'
link Linkedin, url='https://www.linkedin.com/company/astek-diagnostics/'
StaticText © 2023 Astek Diagnostics
RootWebArea Solution - Astek Diagnostics, focused, url='https://astekdx.com/solution'
main
navigation
link Home, url='https://astekdx.com/'
link Problem, url='https://astekdx.com/problem'
Show more
link Solution, url='https://astekdx.com/solution'
link Grand vision, url='https://astekdx.com/grand-vision'
link About us, url='https://astekdx.com/about-us'
link In the news, url='https://astekdx.com/in-the-news'
link Careers, url='https://astekdx.com/careers'
link Get in touch, url='https://astekdx.com/get-in-touch'
link Linkedin, url='https://www.linkedin.com/company/astek-diagnostics/'
StaticText HEADQUARTERS
StaticText 1450 S Rolling Road,
StaticText Halethorpe,
StaticText MD 21227
progressbar value='0'
[124] link, center=(151,49), url='https://astekdx.com/'
[128] link Home, center=(978,49), url='https://astekdx.com/'
[130] link Problem, center=(1074,49), url='https://astekdx.com/problem'
[132] link Solution, center=(1182,49), focused, url='https://astekdx.com/solution'
[134] link Grand vision, center=(1306,49), url='https://astekdx.com/grand-vision'
[136] link About us, center=(1434,49), url='https://astekdx.com/about-us'
[138] link In the news, center=(1556,49), url='https://astekdx.com/in-the-news'
[140] link Careers, center=(1672,49), url='https://astekdx.com/careers'
[142] link Get in touch, center=(1792,49), url='https://astekdx.com/get-in-touch'
main
image, url='https://astekdx.com/images/solution-cover.webp'
heading Our solution
heading Simplified diagnostic process
heading The JIDDU platform unlocks effortless diagnostics, simplifying complex tests with minimal training
paragraph
StaticText Our benchtop analyzer can identify the presence of a bacterial infection in urine and then perform antibiotic susceptibility testing (AST) of the bacterium in one hour. This will inform physicians which antibiotics would be best to give to patients in a short period of time.
heading How it works
paragraph
StaticText 1
heading Place the sample into the cartidge
paragraph
StaticText The sample is placed in a specialized microfluidic cartridge. The type of cartridge utilized varies with the sample type. Once attached, the cartridge is placed in the device and the automated testing process begins.
image, url='https://astekdx.com/images/step-1.webp'
paragraph
StaticText 2
heading Bacteria from the sample is captured
paragraph
StaticText Through an automated filtering process, the bacteria is captured from the sample. For the blood panel, this capturing process incorporates a step to eliminate hemoglobin from lysed blood cells.
image, url='https://astekdx.com/images/step-2.webp'
paragraph
StaticText 3
heading Cultivation and antibiotic testing
paragraph
StaticText The sample is subdivided into multiple channels, allowing it to be mixed with specified antibiotics, as well as have two control channels. Once divided and mixed, the sample channels are cultivated for 35 minutes in a conducive media.
image, url='https://astekdx.com/images/step-3.webp'
paragraph
StaticText 4
heading Detection of bacteria presence
paragraph
StaticText The sample channels mix with specified reagents before moving to an analysis chamber. After 15 minutes, the device is able to confirm the presence of bacteria in the sample as well as provide antibiotic sensitivity results for the pre-selected antibiotics.
image, url='https://astekdx.com/images/step-4.webp'
image, url='https://astekdx.com/images/1-hour-results.svg'
heading 1-Hour Results
paragraph
StaticText Rapid UTI detection
paragraph
StaticText Antibiotic sensitivity indication
image, url='https://astekdx.com/images/point-of-care.svg'
heading Point-of-Care Testing
paragraph
StaticText Actionable results
paragraph
StaticText Expedited treatment
image, url='https://astekdx.com/images/ease-of-use.svg'
heading Ease of Use
paragraph
StaticText Basic training requirement
paragraph
StaticText Automated testing & Disposable cartridges
image, url='https://astekdx.com/images/cost-effective.svg'
heading Cost Effectiveness
paragraph
StaticText $10K as a one-time device purchase
paragraph
StaticText $50 per test cartridge
image, url='https://astekdx.com/images/technology-cover.webp'
heading Technology overview
heading Metabolic activity detection
heading The technology behind the JIDDU system translates metabolic activity into rapid and actionable results
paragraph
StaticText Astek Diagnostics’ revolutionary diagnostic platform leverages microfluidics and is comprised of two distinct parts - a separation chamber and an analyzer. The bacteria is first isolated from urine in the separation chamber, and then metabolic activity is measured through an ultra-sensitive detector using fluorescent dye. This metabolic activity is used to determine antibiotic susceptibility.
heading Metabolic activity example
paragraph
StaticText Sample
progressbar value='72'
paragraph
StaticText TMP-SMX (Bactrim)
progressbar value='56'
paragraph
StaticText Ceftriaxone
progressbar value='24'
paragraph
StaticText Levofloxacin
progressbar value='18'
paragraph
StaticText Nitrofurantoin
progressbar value='24'
paragraph
StaticText Cephalexin
progressbar value='2'
status Badge, atomic
paragraph
StaticText A high metabolic activity shows that an infection is present
status Badge, atomic
paragraph
StaticText TMP-SMX (marketed as Bactrim) is the go-to drug administered for UTIs
status Badge, atomic
paragraph
StaticText A decline in metabolic activity indicates the antibiotic is working
image, url='https://astekdx.com/images/jiddu-footer.webp'
heading Be among the first to experience our technology
link Get in touch, url='https://astekdx.com/get-in-touch'
separator, orientation='horizontal'
link, url='https://astekdx.com/'
image, url='https://astekdx.com/images/tile-inverted.svg'
StaticText WHAT WE DO
link Home, url='https://astekdx.com/'
link Problem, url='https://astekdx.com/problem'
link Solution, url='https://astekdx.com/solution'
link Grand vision, url='https://astekdx.com/grand-vision'
StaticText NEWS
link In the news, url='https://astekdx.com/in-the-news'
StaticText COMPANY
link Careers, url='https://astekdx.com/careers'
link Get in touch, url='https://astekdx.com/get-in-touch'
separator, orientation='horizontal'
StaticText CONTACT
link info@astekdx.com, url='https://astekdx.com/get-in-touch'
StaticText HEADQUARTERS
StaticText 1450 S Rolling Road,
StaticText Halethorpe, Baltimore,
StaticText MD 21227
separator, orientation='horizontal'
link Linkedin, url='https://www.linkedin.com/company/astek-diagnostics/'
StaticText © 2023 Astek Diagnostics
Reasoning for action: By clicking the 'Solution' link, I move from the 'Problem' page to the page dedicated to how Astek Diagnostics tackles AMR. This is a crucial next step in fulfilling the user story because it allows me to gather information about the specific solutions offered, which is necessary for understanding how to make better-informed treatment decisions for patients affected by UTIs.
Action: click(132) # Click on the 'Solution' link to explore how Astek Diagnostics addresses the problem of AMR.
Change Description: The browser transitioned from the 'Problem' page to the 'Solution' page of Astek Diagnostics, displaying new content that focuses on their diagnostic process, technology, and rapid testing results related to antimicrobial resistance (AMR). The navigation links remained unchanged, but the main content now features detailed descriptions of the JIDDU platform and its effectiveness in addressing AMR.
Screenshot before:Screenshot after:---
Step 3:
Url (before/after):
https://astekdx.com/solution
https://astekdx.com/grand-vision
Content (before/after):
RootWebArea Solution - Astek Diagnostics, focused, url='https://astekdx.com/solution'
main
navigation
link Home, url='https://astekdx.com/'
link Problem, url='https://astekdx.com/problem'
Show more
link Solution, url='https://astekdx.com/solution'
link Grand vision, url='https://astekdx.com/grand-vision'
link About us, url='https://astekdx.com/about-us'
link In the news, url='https://astekdx.com/in-the-news'
link Careers, url='https://astekdx.com/careers'
link Get in touch, url='https://astekdx.com/get-in-touch'
link Linkedin, url='https://www.linkedin.com/company/astek-diagnostics/'
StaticText HEADQUARTERS
StaticText 1450 S Rolling Road,
StaticText Halethorpe,
StaticText MD 21227
progressbar value='0'
[124] link, center=(151,49), url='https://astekdx.com/'
[128] link Home, center=(978,49), url='https://astekdx.com/'
[130] link Problem, center=(1074,49), url='https://astekdx.com/problem'
[132] link Solution, center=(1182,49), focused, url='https://astekdx.com/solution'
[134] link Grand vision, center=(1306,49), url='https://astekdx.com/grand-vision'
[136] link About us, center=(1434,49), url='https://astekdx.com/about-us'
[138] link In the news, center=(1556,49), url='https://astekdx.com/in-the-news'
[140] link Careers, center=(1672,49), url='https://astekdx.com/careers'
[142] link Get in touch, center=(1792,49), url='https://astekdx.com/get-in-touch'
main
image, url='https://astekdx.com/images/solution-cover.webp'
heading Our solution
heading Simplified diagnostic process
heading The JIDDU platform unlocks effortless diagnostics, simplifying complex tests with minimal training
paragraph
StaticText Our benchtop analyzer can identify the presence of a bacterial infection in urine and then perform antibiotic susceptibility testing (AST) of the bacterium in one hour. This will inform physicians which antibiotics would be best to give to patients in a short period of time.
heading How it works
paragraph
StaticText 1
heading Place the sample into the cartidge
paragraph
StaticText The sample is placed in a specialized microfluidic cartridge. The type of cartridge utilized varies with the sample type. Once attached, the cartridge is placed in the device and the automated testing process begins.
image, url='https://astekdx.com/images/step-1.webp'
paragraph
StaticText 2
heading Bacteria from the sample is captured
paragraph
StaticText Through an automated filtering process, the bacteria is captured from the sample. For the blood panel, this capturing process incorporates a step to eliminate hemoglobin from lysed blood cells.
image, url='https://astekdx.com/images/step-2.webp'
paragraph
StaticText 3
heading Cultivation and antibiotic testing
paragraph
StaticText The sample is subdivided into multiple channels, allowing it to be mixed with specified antibiotics, as well as have two control channels. Once divided and mixed, the sample channels are cultivated for 35 minutes in a conducive media.
image, url='https://astekdx.com/images/step-3.webp'
paragraph
StaticText 4
heading Detection of bacteria presence
paragraph
StaticText The sample channels mix with specified reagents before moving to an analysis chamber. After 15 minutes, the device is able to confirm the presence of bacteria in the sample as well as provide antibiotic sensitivity results for the pre-selected antibiotics.
image, url='https://astekdx.com/images/step-4.webp'
image, url='https://astekdx.com/images/1-hour-results.svg'
heading 1-Hour Results
paragraph
StaticText Rapid UTI detection
paragraph
StaticText Antibiotic sensitivity indication
image, url='https://astekdx.com/images/point-of-care.svg'
heading Point-of-Care Testing
paragraph
StaticText Actionable results
paragraph
StaticText Expedited treatment
image, url='https://astekdx.com/images/ease-of-use.svg'
heading Ease of Use
paragraph
StaticText Basic training requirement
paragraph
StaticText Automated testing & Disposable cartridges
image, url='https://astekdx.com/images/cost-effective.svg'
heading Cost Effectiveness
paragraph
StaticText $10K as a one-time device purchase
paragraph
StaticText $50 per test cartridge
image, url='https://astekdx.com/images/technology-cover.webp'
heading Technology overview
heading Metabolic activity detection
heading The technology behind the JIDDU system translates metabolic activity into rapid and actionable results
paragraph
StaticText Astek Diagnostics’ revolutionary diagnostic platform leverages microfluidics and is comprised of two distinct parts - a separation chamber and an analyzer. The bacteria is first isolated from urine in the separation chamber, and then metabolic activity is measured through an ultra-sensitive detector using fluorescent dye. This metabolic activity is used to determine antibiotic susceptibility.
heading Metabolic activity example
paragraph
StaticText Sample
progressbar value='72'
paragraph
StaticText TMP-SMX (Bactrim)
progressbar value='56'
paragraph
StaticText Ceftriaxone
progressbar value='24'
paragraph
StaticText Levofloxacin
progressbar value='18'
paragraph
StaticText Nitrofurantoin
progressbar value='24'
paragraph
StaticText Cephalexin
progressbar value='2'
status Badge, atomic
paragraph
StaticText A high metabolic activity shows that an infection is present
status Badge, atomic
paragraph
StaticText TMP-SMX (marketed as Bactrim) is the go-to drug administered for UTIs
status Badge, atomic
paragraph
StaticText A decline in metabolic activity indicates the antibiotic is working
image, url='https://astekdx.com/images/jiddu-footer.webp'
heading Be among the first to experience our technology
link Get in touch, url='https://astekdx.com/get-in-touch'
separator, orientation='horizontal'
link, url='https://astekdx.com/'
image, url='https://astekdx.com/images/tile-inverted.svg'
StaticText WHAT WE DO
link Home, url='https://astekdx.com/'
link Problem, url='https://astekdx.com/problem'
link Solution, url='https://astekdx.com/solution'
link Grand vision, url='https://astekdx.com/grand-vision'
StaticText NEWS
link In the news, url='https://astekdx.com/in-the-news'
StaticText COMPANY
link Careers, url='https://astekdx.com/careers'
link Get in touch, url='https://astekdx.com/get-in-touch'
separator, orientation='horizontal'
StaticText CONTACT
link info@astekdx.com, url='https://astekdx.com/get-in-touch'
StaticText HEADQUARTERS
StaticText 1450 S Rolling Road,
StaticText Halethorpe, Baltimore,
StaticText MD 21227
separator, orientation='horizontal'
link Linkedin, url='https://www.linkedin.com/company/astek-diagnostics/'
StaticText © 2023 Astek Diagnostics
RootWebArea Grand Vision - Astek Diagnostics, focused, url='https://astekdx.com/grand-vision'
main
navigation
link Home, url='https://astekdx.com/'
link Problem, url='https://astekdx.com/problem'
Show more
link Solution, url='https://astekdx.com/solution'
link Grand vision, url='https://astekdx.com/grand-vision'
link About us, url='https://astekdx.com/about-us'
link In the news, url='https://astekdx.com/in-the-news'
link Careers, url='https://astekdx.com/careers'
link Get in touch, url='https://astekdx.com/get-in-touch'
link Linkedin, url='https://www.linkedin.com/company/astek-diagnostics/'
StaticText HEADQUARTERS
StaticText 1450 S Rolling Road,
StaticText Halethorpe,
StaticText MD 21227
progressbar value='0'
[124] link, center=(151,49), url='https://astekdx.com/'
[128] link Home, center=(978,49), url='https://astekdx.com/'
[130] link Problem, center=(1074,49), url='https://astekdx.com/problem'
[132] link Solution, center=(1182,49), url='https://astekdx.com/solution'
[134] link Grand vision, center=(1306,49), focused, url='https://astekdx.com/grand-vision'
[136] link About us, center=(1434,49), url='https://astekdx.com/about-us'
[138] link In the news, center=(1556,49), url='https://astekdx.com/in-the-news'
[140] link Careers, center=(1672,49), url='https://astekdx.com/careers'
[142] link Get in touch, center=(1792,49), url='https://astekdx.com/get-in-touch'
main
image, url='https://astekdx.com/images/grand-vision-cover.webp'
heading Grand vision
heading Focused on developing a multipurpose diagnostic platform
heading Astek Diagnostics has prioritized going to market first with a urine-based test with clinical trials projected to be completed by January 2025.
paragraph
StaticText Our vision is to develop the JIDDU system into a multipurpose diagnostic platform which is able to confirm bacterial infections and assess antibiotic sensitivity across 4 sample types: urine, CSF, effluent, and blood.
image, url='https://astekdx.com/images/jiddu-grand-vision.webp'
heading Present
image, url='https://astekdx.com/images/urine.webp'
heading Urine (Current focus)
heading 2026
image, url='https://astekdx.com/images/csf.webp'
heading CSF (In development)
heading 2027
image, url='https://astekdx.com/images/effluent.webp'
heading Effluent (In development)
heading 2028
image, url='https://astekdx.com/images/blood.webp'
heading Blood (In development)
heading CSF
heading Expected FDA approval: 2026
paragraph
StaticText The traditional two-day wait for culture results is perilous, particularly in meningitis cases—a severe inflammation of the brain and spinal cord's protective membranes. Annually, meningitis affects 600 to 1,000 individuals in the US, with a 10-15% fatality rate and about 20% of survivors enduring permanent disabilities like brain damage or hearing loss.
StaticText In 2015, there were 8.7 million reported cases globally with 379,000 deaths. Even with prompt diagnosis and treatment, 5% to 10% of patients die within 24 to 48 hours post symptom onset. Immediate treatment with antibiotics is crucial for recovery and averting severe complications.
StaticText The JIDDU platform, offering 1-hour antibiotic sensitivity testing, could dramatically shorten this critical time frame, thus enabling timely, effective treatment, and potentially increasing survival rates, and improving patient outcomes in meningitis and other severe infections.
image, url='https://astekdx.com/images/fda-csf.webp'
heading Meningitis confirmation and antibiotic sensitivity in 1 hour
heading Proof of concept data accumulated (12 samples)
heading Active Henry Jackson Foundation grant focused on advancing R&D
heading Effluent
heading Expected FDA approval: 2027
paragraph
StaticText In the US, over 6.5 million individuals are impacted by infected wounds, a figure likely to rise due to antibiotic resistance. Furthermore, surgical site infections (SSIs) present another significant health challenge with a 1-2% incidence rate across all surgical procedures, translating to 1 in 24 surgical patients experiencing an SSI.
StaticText Astek Diagnostics’ work in wound care management aims to address this issue by expediting the identification of bacterial infections and determining antibiotic sensitivity. The JIDDU system significantly reduces the time between wound swabbing and effective antibiotic treatment initiation. This swift action is pivotal in minimizing the severity of wound infections, including SSIs, and tackling antibiotic resistance, thus delivering better wound care outcomes.
image, url='https://astekdx.com/images/fda-effluent.webp'
heading Wound infection (incl. SSI) confirmation and antibiotic sensitivity in 1 hour
heading Proof of concept data accumulated (12 samples)
heading Pending DOD contract focused on advancing R&D
heading Blood
heading Expected FDA approval: 2028
paragraph
StaticText 1.7 million Americans encounter sepsis each year and 270,000 of those cases result in fatalities. Most of those outcomes are due to delayed diagnoses and incorrect antibiotic prescriptions. Around 22% of patients receive ineffective antibiotics, given the standard immediate broad-spectrum antibiotic administration.
StaticText Current diagnostic methods like blood cultures entail prolonged waiting times, unsuitable for high-mortality conditions like sepsis. Astek Diagnostics addresses this with a novel diagnostic assay and an automated microfluidic platform which provides a bacteremia indication and patient-specific antibiotic recommendations within 1 hour. This innovation significantly reduces diagnostic time, thus ensuring timely and effective initiation of antibiotic treatment. The JIDDU system is poised to disrupt the sepsis diagnostic market, given its potential to reduce sepsis-related mortality rates.
image, url='https://astekdx.com/images/fda-blood.webp'
heading Bacteremia confirmation and antibiotic sensitivity test in 1 hour
heading Proof of concept data from a study involving 59 ICU patients
heading Active NSF SBIR Phase 1 grant
image, url='https://astekdx.com/images/jiddu-footer.webp'
heading Be among the first to experience our technology
link Get in touch, url='https://astekdx.com/get-in-touch'
separator, orientation='horizontal'
link, url='https://astekdx.com/'
image, url='https://astekdx.com/images/tile-inverted.svg'
StaticText WHAT WE DO
link Home, url='https://astekdx.com/'
link Problem, url='https://astekdx.com/problem'
link Solution, url='https://astekdx.com/solution'
link Grand vision, url='https://astekdx.com/grand-vision'
StaticText NEWS
link In the news, url='https://astekdx.com/in-the-news'
StaticText COMPANY
link Careers, url='https://astekdx.com/careers'
link Get in touch, url='https://astekdx.com/get-in-touch'
separator, orientation='horizontal'
StaticText CONTACT
link info@astekdx.com, url='https://astekdx.com/get-in-touch'
StaticText HEADQUARTERS
StaticText 1450 S Rolling Road,
StaticText Halethorpe, Baltimore,
StaticText MD 21227
separator, orientation='horizontal'
link Linkedin, url='https://www.linkedin.com/company/astek-diagnostics/'
StaticText © 2023 Astek Diagnostics
Reasoning for action: I chose to click on the 'Grand vision' link because as part of completing the user story, I need to gather comprehensive information about Astek Diagnostics' vision for future advancements in diagnostic technology. This step is crucial as it will provide insights into how the company plans to address the challenges of UTI diagnostics and antimicrobial resistance, which is key to enabling healthcare professionals, like myself, to make better-informed decisions about patient treatments.
Action: click(134) # Click on the 'Grand vision' link to learn more about Astek Diagnostics' overarching goals and vision.
Change Description: The browser navigated from the 'Solution' page to the 'Grand Vision' page of Astek Diagnostics, updating the URL to 'https://astekdx.com/grand-vision' and displaying new content that details the company's vision for developing a multipurpose diagnostic platform, along with various projected timelines and focuses for different sample types.
Screenshot before:Screenshot after:---